Your browser doesn't support javascript.
loading
Cannabinoid Hyperemesis Syndrome and the Consulting Psychiatrist: A Case Study of Diagnosis and Treatment for an Emerging Disorder in Psychiatric Practice.
Kast, Kristopher A; Gershengoren, Liliya.
Affiliation
  • Kast KA; KAST and GERSHENGOREN: Department of Psychiatry, Weill Cornell Medical College and New York-Presbyterian Hospital-Weill Cornell Medical Center, New York, NY.
J Psychiatr Pract ; 24(1): 51-55, 2018 Jan.
Article in En | MEDLINE | ID: mdl-29320384
ABSTRACT
The increasing prevalence of cannabis use in the United States requires awareness of cannabis-related disorders and familiarity with treatment options. We present a case of cannabinoid hyperemesis syndrome that required psychiatric consultation for diagnostic clarification and effective treatment with intravenous haloperidol. Literature from emergency medicine, toxicology, and gastroenterology is reviewed, including proposed diagnostic criteria for cannabinoid hyperemesis syndrome and reported off-label treatment options, with a specific focus on clinical questions facing the practicing psychiatrist regarding this emerging disorder.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vomiting / Cannabinoids / Marijuana Abuse Type of study: Diagnostic_studies / Risk_factors_studies Limits: Adult / Humans / Male Language: En Journal: J Psychiatr Pract Journal subject: PSIQUIATRIA Year: 2018 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vomiting / Cannabinoids / Marijuana Abuse Type of study: Diagnostic_studies / Risk_factors_studies Limits: Adult / Humans / Male Language: En Journal: J Psychiatr Pract Journal subject: PSIQUIATRIA Year: 2018 Document type: Article